查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1381598

RSV 診斷市場：按產品、方法和最終用途分類 - 全球預測 2023-2030

RSV Diagnostics Market by Product (Instruments, Kits & Assays), Methods (Molecular Diagnostics, Rapid Antigen Detection Tests), End-use - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

RSV 診斷市場預計將從 2022 年的 9.7854 億美元增至 2030 年的 19.8465 億美元，預測期內年複合成長率為 9.24%。

RSV 診斷的全球市場

主要市場統計
市場金額：基準年 [2022] 9.7854億美元
預計市場金額[2023] 1,071,540,000 美元
預計市場金額[2030] 1984.65百萬美元 1,984.65 百萬美元
年複合成長率（%） 9.24%
RSV診斷藥物市場-IMG1

FPNV定位矩陣

FPNV定位矩陣是評估RSV診斷市場的重要工具。透過分析與業務策略和產品滿意度相關的關鍵指標來全面評估供應商。這使得使用者能夠根據自己的具體資訊做出明智的決策。進階分析將供應商分為四個像限，每個象限都有不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。這個富有洞察力的框架使決策者能夠充滿信心地駕馭市場。

市場佔有率分析

市場佔有率分析為供應商的市場形勢提供了寶貴的見解。評估對整體收益、客戶群和其他關鍵指標的影響可以全面了解公司的業績及其面臨的競爭環境。該分析還揭示了研究期間的競爭水平，例如市場佔有率成長、碎片化、主導地位和行業整合。

該報告對以下幾個方面提供了寶貴的見解：

1.市場滲透：提供有關市場動態和主要企業產品的全面資訊。

2. 市場開拓：詳細分析新興和成熟細分市場的滲透情況，以突顯利潤豐厚的商機。

3. 市場多元化：有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

5. 產品開發與創新：對未來技術、研發活動和突破性產品開發的智慧洞察。

本報告解決了以下關鍵問題：

1.RSV診斷市場的市場規模與預測為何？

2.RSV診斷市場中哪些產品、細分市場、應用和領域具有最高的投資潛力？

3. RSV診斷市場的競爭策略視窗是什麼？

4.RSV診斷市場的最新技術趨勢與法律規範是什麼？

5.RSV診斷市場主要廠商的市場佔有率為何？

6.進入RSV診斷市場的合適型態和策略手段是什麼？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 人群呼吸道感染疾病盛行率上升
      • 提高感染疾病早期診斷意識
      • 合胞病毒診斷產品核准增加
    • 抑制因素
      • 與 RSV 診斷產品相關的產品召回問題
    • 機會
      • 呼吸道融合病毒（RSV）診斷的進展
      • 基因組學和蛋白​​質組學研究的成長
    • 任務
      • 與目前 RSV 診斷產品和程序相關的限制
  • 市場區隔分析
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章 RSV 診斷市場：依產品

  • 裝置
  • 試劑盒和檢測

第7章 RSV 診斷市場（按方法）

  • 分子診斷
  • 抗原快速檢測試驗

第8章 RSV 診斷市場：依最終用途分類

  • 居家護理
  • 醫院和診所

第9章 美洲 RSV 診斷市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太地區RSV診斷市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的RSV診斷市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 主要企業競爭情境分析

第13章競爭產品組合

  • 主要公司簡介
    • Abbott Laboratories
    • Altona Diagnostics GmbH
    • Atlas Medical GmbH
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories, Inc.
    • bioMerieux SA
    • BTNX Inc.
    • CerTest Biotec SL
    • CTK Biotech, Inc.
    • Danaher Corporation
    • DiaSorin SpA
    • F. Hoffmann-La Roche Ltd.
    • Hologic, Inc.
    • Merck KGaA
    • Meridian Bioscience, Inc.
    • Pro-Lab Diagnostics Inc.
    • Qiagen GmbH
    • Quidel Corporation
    • SA Scientific, Ltd.
    • Sansure Biotech Inc.
    • Sentinel Ch SpA
    • Serion GmbH
    • Siemens Healthcare GmbH
    • Thermo Fisher Scientific Inc.
    • Vela Diagnostics Holding Pte Ltd.
    • Virax Biolabs Group Limited
    • Weldon Biotech, Inc.
  • 主要產品系列

第14章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-C002B1C9986E

The RSV Diagnostics Market is projected to reach USD 1,984.65 million by 2030 from USD 978.54 million in 2022, at a CAGR of 9.24% during the forecast period.

Global RSV Diagnostics Market

KEY MARKET STATISTICS
Base Year Value [2022] USD 978.54 million
Estimated Year Value [2023] USD 1,071.54 million
Forecast Year Value [2030] USD 1,984.65 million
CAGR (%) 9.24%
RSV Diagnostics Market - IMG1

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the RSV Diagnostics Market.

Based on Product, market is studied across Instruments and Kits & Assays. The Instruments is projected to witness significant market share during forecast period.

Based on Methods, market is studied across Molecular Diagnostics and Rapid Antigen Detection Tests. The Molecular Diagnostics is projected to witness significant market share during forecast period.

Based on End-use, market is studied across Home Care and Hospital & Clinics. The Hospital & Clinics is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the RSV Diagnostics Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape RSV Diagnostics Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the RSV Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Altona Diagnostics GmbH, Atlas Medical GmbH, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux SA, BTNX Inc., CerTest Biotec S.L., CTK Biotech, Inc., Danaher Corporation, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Hologic, Inc., Merck KGaA, Meridian Bioscience, Inc., Pro-Lab Diagnostics Inc., Qiagen GmbH, Quidel Corporation, SA Scientific, Ltd., Sansure Biotech Inc., Sentinel Ch S.p.A., Serion GmbH, Siemens Healthcare GmbH, Thermo Fisher Scientific Inc., Vela Diagnostics Holding Pte Ltd., Virax Biolabs Group Limited, and Weldon Biotech, Inc..

The report offers valuable insights on the following aspects:

1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.

2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.

3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.

4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.

5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast for the RSV Diagnostics Market?

2. Which products, segments, applications, and areas hold the highest investment potential in the RSV Diagnostics Market?

3. What is the competitive strategic window for identifying opportunities in the RSV Diagnostics Market?

4. What are the latest technology trends and regulatory frameworks in the RSV Diagnostics Market?

5. What is the market share of the leading vendors in the RSV Diagnostics Market?

6. Which modes and strategic moves are suitable for entering the RSV Diagnostics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. RSV Diagnostics Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of respiratory infections among population
      • 5.1.1.2. Growing awareness about early diagnosis of infectious diseases
      • 5.1.1.3. Increasing approvals for syncytial virus diagnostic product
    • 5.1.2. Restraints
      • 5.1.2.1. Product recall issues associated with RSV diagnostic products
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in respiratory syncytial virus diagnosis
      • 5.1.3.2. Growth in genomics and proteomics research
    • 5.1.4. Challenges
      • 5.1.4.1. Limitations associated with current RSV diagnostic products and procedures
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. RSV Diagnostics Market, by Product

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Kits & Assays

7. RSV Diagnostics Market, by Methods

  • 7.1. Introduction
  • 7.2. Molecular Diagnostics
  • 7.3. Rapid Antigen Detection Tests

8. RSV Diagnostics Market, by End-use

  • 8.1. Introduction
  • 8.2. Home Care
  • 8.3. Hospital & Clinics

9. Americas RSV Diagnostics Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific RSV Diagnostics Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa RSV Diagnostics Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. Abbott Laboratories
    • 13.1.2. Altona Diagnostics GmbH
    • 13.1.3. Atlas Medical GmbH
    • 13.1.4. Becton, Dickinson and Company
    • 13.1.5. Bio-Rad Laboratories, Inc.
    • 13.1.6. bioMerieux SA
    • 13.1.7. BTNX Inc.
    • 13.1.8. CerTest Biotec S.L.
    • 13.1.9. CTK Biotech, Inc.
    • 13.1.10. Danaher Corporation
    • 13.1.11. DiaSorin S.p.A.
    • 13.1.12. F. Hoffmann-La Roche Ltd.
    • 13.1.13. Hologic, Inc.
    • 13.1.14. Merck KGaA
    • 13.1.15. Meridian Bioscience, Inc.
    • 13.1.16. Pro-Lab Diagnostics Inc.
    • 13.1.17. Qiagen GmbH
    • 13.1.18. Quidel Corporation
    • 13.1.19. SA Scientific, Ltd.
    • 13.1.20. Sansure Biotech Inc.
    • 13.1.21. Sentinel Ch S.p.A.
    • 13.1.22. Serion GmbH
    • 13.1.23. Siemens Healthcare GmbH
    • 13.1.24. Thermo Fisher Scientific Inc.
    • 13.1.25. Vela Diagnostics Holding Pte Ltd.
    • 13.1.26. Virax Biolabs Group Limited
    • 13.1.27. Weldon Biotech, Inc.
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. RSV DIAGNOSTICS MARKET RESEARCH PROCESS
  • FIGURE 2. RSV DIAGNOSTICS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. RSV DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. RSV DIAGNOSTICS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 5. RSV DIAGNOSTICS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 6. RSV DIAGNOSTICS MARKET DYNAMICS
  • FIGURE 7. RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 8. RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2022 VS 2030 (%)
  • FIGURE 10. RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2022 VS 2030 (%)
  • FIGURE 12. RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS RSV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 14. AMERICAS RSV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES RSV DIAGNOSTICS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
  • FIGURE 16. UNITED STATES RSV DIAGNOSTICS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC RSV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC RSV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA RSV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA RSV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 21. RSV DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 22. RSV DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. RSV DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. RSV DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 6. RSV DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. RSV DIAGNOSTICS MARKET SIZE, BY KITS & ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 9. RSV DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. RSV DIAGNOSTICS MARKET SIZE, BY RAPID ANTIGEN DETECTION TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 12. RSV DIAGNOSTICS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. RSV DIAGNOSTICS MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS RSV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 27. MEXICO RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. MEXICO RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES RSV DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. ASIA-PACIFIC RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC RSV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 38. AUSTRALIA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. AUSTRALIA RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 40. AUSTRALIA RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 41. CHINA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. CHINA RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 43. CHINA RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 44. INDIA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. INDIA RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 46. INDIA RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 47. INDONESIA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. INDONESIA RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 49. INDONESIA RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 50. JAPAN RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. JAPAN RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 52. JAPAN RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 53. MALAYSIA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. MALAYSIA RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 55. MALAYSIA RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 56. PHILIPPINES RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. PHILIPPINES RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 58. PHILIPPINES RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 59. SINGAPORE RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. SINGAPORE RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 61. SINGAPORE RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 62. SOUTH KOREA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. SOUTH KOREA RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 64. SOUTH KOREA RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 65. TAIWAN RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. TAIWAN RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 67. TAIWAN RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 68. THAILAND RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. THAILAND RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 70. THAILAND RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 71. VIETNAM RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. VIETNAM RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 73. VIETNAM RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 74. EUROPE, MIDDLE EAST & AFRICA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA RSV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 78. DENMARK RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. DENMARK RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 80. DENMARK RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 81. EGYPT RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. EGYPT RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 83. EGYPT RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 84. FINLAND RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. FINLAND RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 86. FINLAND RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 87. FRANCE RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. FRANCE RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 89. FRANCE RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 90. GERMANY RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. GERMANY RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 92. GERMANY RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 93. ISRAEL RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. ISRAEL RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 95. ISRAEL RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 96. ITALY RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. ITALY RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 98. ITALY RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 99. NETHERLANDS RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. NETHERLANDS RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 101. NETHERLANDS RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 102. NIGERIA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. NIGERIA RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 104. NIGERIA RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 105. NORWAY RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. NORWAY RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 107. NORWAY RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 108. POLAND RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. POLAND RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 110. POLAND RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 111. QATAR RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. QATAR RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 113. QATAR RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 114. RUSSIA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. RUSSIA RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 116. RUSSIA RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 117. SAUDI ARABIA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. SAUDI ARABIA RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 119. SAUDI ARABIA RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 120. SOUTH AFRICA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. SOUTH AFRICA RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH AFRICA RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 123. SPAIN RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. SPAIN RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 125. SPAIN RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 126. SWEDEN RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. SWEDEN RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 128. SWEDEN RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 129. SWITZERLAND RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. SWITZERLAND RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 131. SWITZERLAND RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 132. TURKEY RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. TURKEY RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 134. TURKEY RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 135. UNITED ARAB EMIRATES RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. UNITED ARAB EMIRATES RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED ARAB EMIRATES RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED KINGDOM RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED KINGDOM RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED KINGDOM RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 141. RSV DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 142. RSV DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 143. RSV DIAGNOSTICS MARKET LICENSE & PRICING